Precision BioSciences Inc. logo

Precision BioSciences Inc.

DTIL | NASDAQ
Chart Builder DCF Calculator
$6.50
-$0.17 (-2.55%)
At close: Sep 21, 2026, 4:00 PM ET
$6.50
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$83.38M
Enterprise Value
$-2.56M
Beta
1.25
Average Volume
377.61K
Shares Outstanding (Diluted)
25.86M
Shares Change YoY
134.07%
Institutional Ownership
65.56%
Exchange
NASDAQ
ISIN
US74019P2074

Price Performance

Price Change 1M
-26.3%
Price Change 3M
-6.5%
Price Change 6M
0.5%
Price Change YTD
58.5%
Price Change 1Y
33.7%
Price Change 3Y
-43.0%
Price Change 5Y
-98.3%
1M CAGR (ann.)
-13.2%
1Y CAGR (ann.)
32.4%
5Y CAGR (ann.)
-55.7%
All-Time CAGR
-44.3%

Valuation

PE Ratio
-2.32
Forward PE
N/A
PEG Ratio
-0.02
Forward PEG
0.11
PS Ratio
1.85
Forward PS
9.40
PB Ratio
1.84
P/FCF Ratio
-1.30
P/Adj. FCF Ratio
-1.14
P/OCF Ratio
-3.23
EV/Sales
-0.06
EV/EBIT
0.05
EV/EBITDA
0.05
EV/FCF
0.04
Earnings Yield
-43.1%
FCF Yield
-76.6%
Adj. FCF Yield
-87.9%

Financial Health

Net Cash
$85.94M
Total Debt
$1.61M
Cash & Short-Term Investments
$87.55M
Total Assets
$125.92M
Current Ratio
12.82
Quick Ratio
12.82
Debt / Equity Ratio
0.62
Debt / EBITDA
-0.03
Debt / FCF
-0.03
OCF / Debt
-39.70
Interest Coverage
-27.55
Altman Z-Score
-6.03
Piotroski F-Score
5

Margins & Profitability

Gross Profit Margin
100.0%
Operating Profit Margin
-80.8%
EBITDA Margin
-111.1%
Net Profit Margin
-117.0%
FCF Margin
-141.8%
Adj. FCF Margin
-162.6%
SBC / Revenue
17.4%
SBC Impact (per share)
-14.7%

Returns

Return on Assets
-41.9%
Return on Equity
-91.6%
Return on Invested Capital
-30.2%
Return on Capital Employed
-30.6%
Return on Tangible Assets
-42.2%

Historical Growth (CAGR)

Revenue CAGR 3Y
-1.1%
Revenue CAGR 5Y
-15.0%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-45.0%
EPS CAGR 5Y
61.5%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
1.5%
FCF CAGR 5Y
9.6%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
12
EPS Growth Next 3Y
8.7%
Revenue Growth Next 3Y
-20.2%
Earnings Date
Nov 1, 2026
EPS Estimate (next Q)
-$0.85
EPS Growth Est (next Q)
-53.8%
Revenue Est (next Q)
$1.38M
Revenue Growth Est (next Q)
10476.9%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$20
Price Target Upside
207.7%

Cash Flow

Operating Cash Flow
$-63.84M
Free Cash Flow
$-63.91M
Adj. Free Cash Flow
$-73.28M
FCF Per Share
-$2.01
OCF Per Share
-$2.01
OCF/S Ratio
-115.2%

Income Statement

Revenue
$45.06M
Gross Profit
$45.06M
Operating Income
$-36.4M
EBITDA
$-50.05M
Net Income
$-52.73M
EPS (Diluted)
-$2.80
Revenue / Employee
$672.46K
Profit / Employee
$-787.04K
Employees
67

© 2026 bestshares.com. All rights reserved.